Subendocardial ischemia in hypertrophic cardiomyopathy

Journal of Cardiology

Volumn 63, Issue 2, 2014, Pages 89-94

  Kawasaki, Tatsuya ^a   Sugihara, Hiroki ^a  

^a MATSUSHITA MEMORIAL HOSPITAL   (Japan)

Author keywords

Cardiomyopathies; Hypertrophic; Ischemia; Subendocardium

Indexed keywords

DILTIAZEM; VERAPAMIL;

ECHOCARDIOGRAPHY; ELECTROCARDIOGRAM; ELECTROCARDIOGRAPHY; HEART LEFT VENTRICLE HYPERTROPHY; HEART LEFT VENTRICLE OUTFLOW TRACT OBSTRUCTION; HEART MUSCLE ISCHEMIA; HUMAN; HYPERTENSION; HYPERTROPHIC CARDIOMYOPATHY; NUCLEAR MAGNETIC RESONANCE IMAGING; POSITRON EMISSION TOMOGRAPHY; PROGNOSIS; REVIEW; SCINTIGRAPHY; THORAX PAIN;

CARDIOMYOPATHIES; HYPERTROPHIC; ISCHEMIA; SUBENDOCARDIUM;

BICYCLO COMPOUNDS, HETEROCYCLIC; CARDIOMYOPATHY, HYPERTROPHIC; DIAGNOSTIC IMAGING; DILTIAZEM; ECHOCARDIOGRAPHY; FOLLOW-UP STUDIES; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; MYOCARDIAL ISCHEMIA; POSITRON-EMISSION TOMOGRAPHY; PROGNOSIS; PROSPECTIVE STUDIES; PYRIMIDINONES; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON; VERAPAMIL;

EID: 84893729284     PISSN: 09145087     EISSN: 18764738     Source Type: Journal    
DOI: 10.1016/j.jjcc.2013.10.005     Document Type: Review

References (43)

1. Brock R. Functional obstruction of the left ventricle; acquired aortic subvalvar stenosis. Guys Hosp Rep 1957, 106:221-238.
2. Teare D. Asymmetrical hypertrophy of the heart in young adults. Br Heart J 1958, 20:1-8.
3. Bulkley B.H., Rouleau J., Strauss H.W., Pitt B. Idiopathic hypertrophic subaortic stenosis: detection by thallium 201 myocardial perfusion imaging. N Engl J Med 1975, 293:1113-1116.
4. Büll U., Niendorf H.P., Strauer B.E., Hast B. Evaluation of myocardial function with the 201thallium scintimetry in various diseases of the heart. A correlative study based on 100 patients. Eur J Nucl Med 1976, 1:125-136.
5. O'Gara P.T., Bonow R.O., Maron B.J., Damske B.A., Van Lingen A., Bacharach S.L., Larson S.M., Epstein S.E. Myocardial perfusion abnormalities in patients with hypertrophic cardiomyopathy. Circulation 1987, 76:1214-1223.
6. Udelson J.E., Bonow R.O., O'Gara P.T., Maron B.J., Van Lingen A., Bacharach S.L., Epstein S.E. Verapamil prevents silent myocardial perfusion abnormalities during exercise in asymptomatic patients with hypertrophic cardiomyopathy. Circulation 1989, 79:1052-1060.
7. Cannon R.O., Dilsizian V., O'Gara P.T., Udelson J.E., Schenke W.H., Quyyumi A., Fananapazir L., Bonow R.O. Myocardial metabolic, hemodynamic, and electrocardiographic significance of reversible thallium-201 abnormalities in hypertrophic cardiomyopathy. Circulation 1991, 83:1660-1667.
8. Maron M.S., Olivotto I., Maron B.J., Prasad S.K., Cecchi F., Udelson J.E., Camici P.G. The case for myocardial ischemia in hypertrophic cardiomyopathy. J Am Coll Cardiol 2009, 54:866-875.
9. Cecchi F., Olivotto I., Gistri R., Lorenzoni R., Chiriatti G., Camici P.G. Coronary microvascular dysfunction and prognosis in hypertrophic cardiomyopathy. N Engl J Med 2003, 349:1027-1035.
10. Sugihara H., Shiga K., Umamoto I., Harada Y., Katahira T., Nakagawa T., Nakamura T., Matsubara K., Terashima S., Azuma A., Katsume H., Nakagawa M. Assessment of transient dilation of the LV cavity in patients with hypertrophic cardiomyopathy by exercise thallium-201 scintigraphy. Kaku Igaku 1990, 27:1281-1289. [in Japanese].
11. Nakamura T., Sakamoto K., Yamano T., Kikkawa M., Zen K., Hikosaka T., Kubota T., Azuma A., Nishimura T. Increased plasma brain natriuretic peptide level as a guide for silent myocardial ischemia in patients with non-obstructive hypertrophic cardiomyopathy. J Am Coll Cardiol 2002, 39:1657-1663.
12. Kawasaki T., Azuma A., Kuribayashi T., Taniguchi T., Miyai N., Kamitani T., Kawasaki S., Matsubara H., Sugihara H. Resting ST-segment depression predicts exercise-induced subendocardial ischemia in patients with hypertrophic cardiomyopathy. Int J Cardiol 2006, 107:267-274.
13. Kawasaki T., Yamano M., Sakai C., Harimoto K., Miki S., Kamitani T., Sugihara H. Diagnostic performance of ultrasonic tissue characterization for subendocardial ischaemia in patients with hypertrophic cardiomyopathy. Eur Heart J Cardiovasc Imaging 2013, 14:790-796.
14. Miranda C.P., Lehmann K.G., Froelicher V.F. Correlation between resting ST segment depression, exercise testing, coronary angiography, and long-term prognosis. Am Heart J 1991, 122:1617-1628.
15. Akakabe Y., Kawasaki T., Yamano M., Miki S., Kamitani T., Kuribayashi T., Matsubara H., Sugihara H. Septal Q wave as a marker of septal ischemia in hypertrophic cardiomyopathy. Circ J 2008, 72:953-957.
16. Xiao H.B., Gibson D.G. Absent septal q wave on electrocardiogram: a forgotten marker of myocardial disease. Int J Cardiol 1996, 53:1-4.
17. Famularo M.A., Paliwal Y., Redd R., Ellestad M.H. Identification of septal ischemia during exercise by Q-wave analysis: correlation with coronary angiography. Am J Cardiol 1983, 51:440-443.
18. Kawasaki T., Akakabe Y., Yamano M., Miki S., Kamitani T., Kuribayashi T., Sugihara H. R-wave amplitude response to myocardial ischemia in hypertrophic cardiomyopathy. J Electrocardiol 2008, 41:68-71.
19. Olivotto I., Maron B.J., Montereggi A., Mazzuoli F., Dolara A., Cecchi F. Prognostic value of systemic blood pressure response during exercise in a community-based patient population with hypertrophic cardiomyopathy. J Am Coll Cardiol 1999, 33:2044-2051.
20. Spirito P., Seidman C.E., McKenna W.J., Maron B.J. The management of hypertrophic cardiomyopathy. N Engl J Med 1997, 336:775-785.
21. Yoshida N., Ikeda H., Wada T., Matsumoto A., Maki S., Muro A., Shibata A., Imaizumi T. Exercise-induced abnormal blood pressure responses are related to subendocardial ischemia in hypertrophic cardiomyopathy. J Am Coll Cardiol 1998, 32:1938-1942.
22. Kawasaki T., Azuma A., Kuribayashi T., Akakabe Y., Yamano M., Miki S., Sawada T., Kamitani T., Matsubara H., Sugihara H. Vagal enhancement due to subendocardial ischemia as a cause of abnormal blood pressure response in hypertrophic cardiomyopathy. Int J Cardiol 2008, 129:59-64.
23. Barber M.J., Mueller T.M., Davies B.G., Zipes D.P. Phenol topically applied to canine left ventricular epicardium interrupts sympathetic but not vagal afferents. Circ Res 1984, 55:532-544.
24. Zipes D.P. Influence of myocardial ischemia and infarction on autonomic innervation of heart. Circulation 1990, 82:1095-1105.
25. Kawano H., Okada R., Yano K. Histological study on the distribution of autonomic nerves in the human heart. Heart Vessels 2003, 18:32-39.
26. Thorén P. Role of cardiac vagal C-fibers in cardiovascular control. Rev Physiol Biochem Pharmacol 1979, 86:1-94.
27. Kawasaki T., Akakabe Y., Yamano M., Miki S., Kamitani T., Kuribayashi T., Sugihara H. Gated single-photon emission computed tomography detects subendocardial ischemia in hypertrophic cardiomyopathy. Circ J 2007, 71:256-260.
28. Lin L.C., Kao H.L., Wu C.C., Ho Y.L., Lee Y.T. Alterations of myocardial ultrasonic tissue characterization by coronary angioplasty in patients with chronic stable coronary artery disease. Ultrasound Med Biol 2001, 27:1191-1198.
29. Nishimura Y., Katafuchi T., Hirase Y., Sagoh M., Oka H., Mori H., Murase K. Measurement of left ventricular chamber and myocardial volume in hypertrophic cardiomyopathy patients by ECG-gated myocardial perfusion SPECT: application of a newly developed edge-detection algorithm. Nihon Hoshasen Gijutsu Gakkai Zasshi 2002, 58:1586-1591. [in Japanese].
30. He Z.X., Shi R.F., Wu Y.J., Tian Y.Q., Liu X.J., Wang S.W., Shen R., Qin X.W., Gao R.L., Narula J., Jain D. Direct imaging of exercise-induced myocardial ischemia with fluorine-18-labeled deoxyglucose and Tc-99m-sestamibi in coronary artery disease. Circulation 2003, 108:1208-1213.
31. Yamano M., Kawasaki T., Sugihara H. Direct imaging of myocardial ischaemia with [18F]fluorodeoxyglucose on exercise PET in hypertrophic cardiomyopathy. Heart 2009, 95:1051.
32. Ordovas K.G., Higgins C.B. Delayed contrast enhancement on MR images of myocardium: past, present, future. Radiology 2011, 261:358-374.
33. Nojiri A., Hongo K., Kawai M., Komukai K., Sakuma T., Taniguchi I., Yoshimura M. Scoring of late gadolinium enhancement in cardiac magnetic resonance imaging can predict cardiac events in patients with hypertrophic cardiomyopathy. J Cardiol 2011, 58:253-260.
34. Hombach V., Merkle N., Bernhard P., Rasche V., Rottbauer W. Prognostic significance of cardiac magnetic resonance imaging: update 2010. Cardiol J 2010, 17:549-557.
35. Kaimoto S., Kawasaki T., Kuribayashi T., Yamano M., Miki S., Kamitani T., Matsubara H. Myocardial perfusion abnormality in the area of ventricular septum-free wall junction and cardiovascular events in nonobstructive hypertrophic cardiomyopathy. Int J Cardiovasc Imaging 2012, 28:1829-1839.
36. Maron B.J., Olivotto I., Spirito P., Casey S.A., Bellone P., Gohman T.E., Graham K.J., Burton D.A., Cecchi F. Epidemiology of hypertrophic cardiomyopathy-related death: revisited in a large non-referral-based patient population. Circulation 2000, 102:858-864.
37. Bruder O., Wagner A., Jensen C.J., Schneider S., Ong P., Kispert E.M., Nassenstein K., Schlosser T., Sabin G.V., Sechtem U., Mahrholdt H. Myocardial scar visualized by cardiovascular magnetic resonance imaging predicts major adverse events in patients with hypertrophic cardiomyopathy. J Am Coll Cardiol 2010, 56:875-887.
38. O'Hanlon R., Grasso A., Roughton M., Moon J.C., Clark S., Wage R., Webb J., Kulkarni M., Dawson D., Sulaibeekh L., Chandrasekaran B., Bucciarelli-Ducci C., Pasquale F., Cowie M.R., McKenna W.J., et al. Prognostic significance of myocardial fibrosis in hypertrophic cardiomyopathy. J Am Coll Cardiol 2010, 56:867-874.
39. Goto D., Kinugawa S., Hamaguchi S., Sakakibara M., Tsuchihashi-Makaya M., Yokota T., Yamada S., Yokoshiki H., Tsutsui H. Clinical characteristics and outcomes of dilated phase of hypertrophic cardiomyopathy: report from the registry data in Japan. J Cardiol 2013, 61:65-70. JCARE-CARD Investigators.
40. Pasternac A., Noble J., Streulens Y., Elie R., Henschke C., Bourassa M.G. Pathophysiology of chest pain in patients with cardiomyopathies and normal coronary arteries. Circulation 1982, 65:778-789.
41. Fifer M.A., Vlahakes G.J. Management of symptoms in hypertrophic cardiomyopathy. Circulation 2008, 117:429-439.
42. Taniguchi Y., Sugihara H., Ohtsuki K., Umamoto I., Nakagawa T., Shiga K., Nakamura T., Azuma A., Kohno Y., Nakagawa M. Effect of verapamil on myocardial ischemia in patients with hypertrophic cardiomyopathy: evaluation by exercise thallium-201 SPECT. J Cardiol 1994, 24:45-51. [in Japanese].
43. Sugihara H., Taniguchi Y., Ito K., Terada K., Matsumoto K., Kinoshita N., Azuma A., Ushijima Y., Maeda T., Nakagawa M. Effects of diltiazem on myocardial perfusion abnormalities during exercise in patients with hypertrophic cardiomyopathy. Ann Nucl Med 1998, 12:349-354.